Premialab, Momentum: Crushed by the COVID-19 Vaccine

Featured • November 16, 2020

Momentum: Crushed by the Vaccine

The Momentum factor saw a plunge of unprecedented magnitude in early November. This commentary aims to interpret recent market dynamics from a factor perspective and update participants on the evolving factor environment.

Read more
In Bloomberg this weekend, Premialab CEO Adrien Geliot shared his perspective on the continued role of systematic volatility strategies in institutional portfolios.

Wall Street Strategists Steer Investors to Cross-Asset Hedges

Poseidon Capital Partners appoints Premialab to strengthen QIS-driven portfolio construction

Poseidon Capital Partners appoints Premialab to strengthen QIS-driven portfolio construction

Hedge Fund Selection for Multi-Asset Portfolios

Hedge Fund Selection for Multi-Asset Portfolios

Premialab Partners with Parameta Solutions

Premialab Partners with Parameta Solutions